Calcineurin Inhibition in Deceased Organ Donors: A Systematic Review and Meta-analysis of Preclinical Studies

Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. Methods. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comp...

Full description

Saved in:
Bibliographic Details
Published inTransplantation direct Vol. 9; no. 9; p. e1519
Main Authors D'Aragon, Frédérick, Rousseau, William, Breau, Ruth, Aminaei, Daniel, Ichai, Carole, Boyd, Gordon J., Burns, Karen E. A., Cardinal, Héloïse, Carrier, François-Martin, Chassé, Michaël, Chaudhury, Prosanto, Dhanani, Sonny, English, Shane W., Frenette, Anne Julie, Hanna, Steven, Knoll, Gregory, Lauzier, François, Oczkowski, Simon, Rochwerg, Bram, Shamseddin, Khaled, Slessarev, Marat, Treleaven, Darin, Turgeon, Alexis F., Weiss, Matthew J., Selzner, Markus, Meade, Maureen O.
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.09.2023
Wolters Kluwer
Subjects
Online AccessGet full text
ISSN2373-8731
2373-8731
DOI10.1097/TXD.0000000000001519

Cover

Loading…
Abstract Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. Methods. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively. Results. Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47). Conclusions. Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application.
AbstractList Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. Methods. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively. Results. Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47). Conclusions. Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application.
Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes.BackgroundPreconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes.We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively.MethodsWe searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively.Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47).ResultsEighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47).Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application.ConclusionsAlthough this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application.
Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively. Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47). Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application.
Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia–reperfusion injury to improve transplant outcomes. Methods. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively. Results. Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47). Conclusions. Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application.
Author Breau, Ruth
Carrier, François-Martin
Treleaven, Darin
Ichai, Carole
English, Shane W.
Chaudhury, Prosanto
Meade, Maureen O.
Weiss, Matthew J.
Burns, Karen E. A.
Cardinal, Héloïse
D'Aragon, Frédérick
Aminaei, Daniel
Shamseddin, Khaled
Selzner, Markus
Chassé, Michaël
Lauzier, François
Slessarev, Marat
Turgeon, Alexis F.
Rochwerg, Bram
Hanna, Steven
Oczkowski, Simon
Frenette, Anne Julie
Knoll, Gregory
Rousseau, William
Dhanani, Sonny
Boyd, Gordon J.
Author_xml – sequence: 1
  givenname: Frédérick
  surname: D'Aragon
  fullname: D'Aragon, Frédérick
  organization: Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, QC, Canada
– sequence: 2
  givenname: William
  surname: Rousseau
  fullname: Rousseau, William
  organization: Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC, Canada
– sequence: 3
  givenname: Ruth
  surname: Breau
  fullname: Breau, Ruth
  organization: Department of Health Evidence and Impact, McMaster University, Hamilton, ON, Canada
– sequence: 4
  givenname: Daniel
  surname: Aminaei
  fullname: Aminaei, Daniel
  organization: Department of Health Evidence and Impact, McMaster University, Hamilton, ON, Canada
– sequence: 5
  givenname: Carole
  surname: Ichai
  fullname: Ichai, Carole
  organization: Intensive Care Unit, University Hospital of Nice, Nice, France
– sequence: 6
  givenname: Gordon J.
  surname: Boyd
  fullname: Boyd, Gordon J.
  organization: Department of Critical Care Medicine, Queen's University, Kingston, ON, Canada
– sequence: 7
  givenname: Karen E. A.
  surname: Burns
  fullname: Burns, Karen E. A.
  organization: Li Ka Shing Knowledge Institute, University Health Toronto-St. Michael's Hospital, Toronto, ON, Canada
– sequence: 8
  givenname: Héloïse
  surname: Cardinal
  fullname: Cardinal, Héloïse
  organization: Department of Nephrology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada
– sequence: 9
  givenname: François-Martin
  surname: Carrier
  fullname: Carrier, François-Martin
  organization: Department of Critical Care, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada
– sequence: 10
  givenname: Michaël
  surname: Chassé
  fullname: Chassé, Michaël
  organization: Department of Critical Care, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada
– sequence: 11
  givenname: Prosanto
  surname: Chaudhury
  fullname: Chaudhury, Prosanto
  organization: Department of Surgery and Oncology, McGill University, Montreal, QC, Canada
– sequence: 12
  givenname: Sonny
  surname: Dhanani
  fullname: Dhanani, Sonny
  organization: Ottawa Hospital Research Institute, Ottawa, ON, Canada
– sequence: 13
  givenname: Shane W.
  surname: English
  fullname: English, Shane W.
  organization: Department of Medicine, University of Ottawa, Ottawa, ON, Canada
– sequence: 14
  givenname: Anne Julie
  surname: Frenette
  fullname: Frenette, Anne Julie
  organization: Faculty of Pharmacy, Université de Montreal, Montreal, QC, Canada
– sequence: 15
  givenname: Steven
  surname: Hanna
  fullname: Hanna, Steven
  organization: Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC, Canada
– sequence: 16
  givenname: Gregory
  surname: Knoll
  fullname: Knoll, Gregory
  organization: Division of Nephrology, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada
– sequence: 17
  givenname: François
  surname: Lauzier
  fullname: Lauzier, François
  organization: Population Health and Optimal Health Practice Research Unit, CHU de Québec-Université Laval Research Center, Quebec City, QC, Canada
– sequence: 18
  givenname: Simon
  surname: Oczkowski
  fullname: Oczkowski, Simon
  organization: Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada
– sequence: 19
  givenname: Bram
  surname: Rochwerg
  fullname: Rochwerg, Bram
  organization: Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada
– sequence: 20
  givenname: Khaled
  surname: Shamseddin
  fullname: Shamseddin, Khaled
  organization: Division of Nephrology, Department of Medicine, Queen's University, Kingston, ON, Canada
– sequence: 21
  givenname: Marat
  surname: Slessarev
  fullname: Slessarev, Marat
  organization: Division of Critical Care, Department of Medicine, Western University, London, ON, Canada
– sequence: 22
  givenname: Darin
  surname: Treleaven
  fullname: Treleaven, Darin
  organization: Department of Medicine, McMaster University, Hamilton, ON, Canada
– sequence: 23
  givenname: Alexis F.
  surname: Turgeon
  fullname: Turgeon, Alexis F.
  organization: Departments of Anesthesiology and Critical Care Medicine, Université Laval, Quebec City, QC, Canada
– sequence: 24
  givenname: Matthew J.
  surname: Weiss
  fullname: Weiss, Matthew J.
  organization: Transplant Québec, QC, Canada
– sequence: 25
  givenname: Markus
  surname: Selzner
  fullname: Selzner, Markus
  organization: Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada
– sequence: 26
  givenname: Maureen O.
  surname: Meade
  fullname: Meade, Maureen O.
  organization: Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37649790$$D View this record in MEDLINE/PubMed
BookMark eNqFksFuEzEQhleoiJbSN0Boj1xS7LXXu-4FVSmUSEVFtEjcrFl7NnFx7GLvNsrb1yGlSnsAX-wZ__83I828LvZ88FgUbyk5pkQ2H65_nh2TnUNrKl8UBxVr2KRtGN3bee8XRyndbERcCF6xV8U-awSXjSQHxXIKTluPY7S-nPmF7exggy9zdIYaIaEpL-Mcchh8iOmkPC2v1mnAJQxWl9_xzuKqBG_KrzjABDy4dbKpDH35LaJ21lsNrrwaRmMxvSle9uASHj3ch8WPz5-up18mF5fns-npxUTzppYTMJURtRFEm4p1EpDmgAlEAWAoqwllROgGqdZA-5pTaYxmvUQpCQiq2WEx23JNgBt1G-0S4loFsOpPIsS5gpj7d6g4AwGt6dtM5l3HOk56JA0VrZGMV5hZH7es27FbotHohwjuCfTpj7cLNQ93ihIuakpIJrx_IMTwe8Q0qKVNGp0Dj2FMqmprKQivGpGl73aLPVb5O7As4FuBjiGliP2jhBK1WQ2VV0M9X41sO3lm03aAzaRzy9b9z9xuzavgBozplxtXGNUCwQ2Lf1vvAUqiz5o
CitedBy_id crossref_primary_10_1136_bmjopen_2024_086777
Cites_doi 10.1186/1471-2288-8-32
10.1111/j.1365-2249.2011.04487.x
10.1016/j.kint.2015.09.002
10.1097/CCM.0b013e3181fa0468
10.1016/j.transproceed.2006.05.002
10.1161/CIRCRESAHA.115.307676
10.1093/ndt/gft488
10.1097/01.TP.0000063408.97289.89
10.1146/annurev.physiol.60.1.619
10.1016/S2213-2600(18)30136-X
10.1172/JCI31892
10.1164/rccm.202201-0033OC
10.1056/NEJMoa0802289
10.1016/j.trim.2010.10.006
10.1007/s12272-009-1138-9
10.1186/1471-2288-14-43
10.3310/hta7250
10.3389/fimmu.2020.01222
10.1093/brain/awm083
10.1016/j.transproceed.2017.12.033
10.1016/S0041-1345(98)02001-6
10.1016/j.healun.2010.05.034
10.1111/ajt.14558
10.1007/s12630-020-01692-7
10.1097/00007890-201007272-01710
10.1111/ajt.16868
10.1111/ajt.16899
10.1097/00007890-199110000-00007
10.2215/CJN.05560519
10.1053/jlts.2003.50020
10.1016/j.jss.2011.04.018
10.1016/S0008-6363(02)00455-8
10.1097/TP.0000000000003136
10.1007/s11934-019-0868-6
10.7326/0003-4819-142-7-200504050-00010
10.1111/ajt.14136
10.18773/austprescr.2006.064
10.1016/j.jss.2005.04.015
10.1097/MOT.0000000000000090
10.1016/j.surg.2006.11.005
10.1590/S1679-45082015RW3161
10.1111/j.1399-0012.1998.tb01101.x
10.1097/XEB.0000000000000065
10.1093/ndt/gfl042
10.1186/s13063-018-2597-4
10.1159/000259900
10.1001/jama.296.14.1731
10.1093/ndt/gfq646
10.2152/jmi.51.76
10.1016/j.transproceed.2005.02.069
10.1242/dmm.016741
10.1016/j.cyto.2008.12.003
10.1097/TP.0b013e3181945332
10.1038/sj.jcbfm.9600064
10.1016/j.jtcvs.2013.07.030
ContentType Journal Article
Copyright Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. 2023
Copyright_xml – notice: Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
– notice: Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. 2023
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1097/TXD.0000000000001519
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2373-8731
ExternalDocumentID oai_doaj_org_article_43a6a8df8ad14bb3b40fe07168d9342e
PMC10465100
37649790
10_1097_TXD_0000000000001519
Genre research-article
Journal Article
GroupedDBID 1J1
53G
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AAUEB
ABASU
ABDIG
ABVCZ
ABXVJ
ABXYN
ABZZY
ACDOF
ACEWG
ACGFS
ACILI
ACLDA
ACXJB
ACXNZ
ACZKN
ADBBV
ADGGA
ADHPY
ADPDF
AEBDS
AFBFQ
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGOPY
AHOMT
AHQNM
AHQVU
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOIJS
AOQMC
BCNDV
BQLVK
DIWNM
EEVPB
ERAAH
EX3
FCALG
GNXGY
GQDEL
GROUPED_DOAJ
HLJTE
HYE
IKREB
IKYAY
M~E
ODMTH
OHYEH
OK1
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OXXIT
RLZ
RPM
TEORI
TSPGW
0R~
AAYXX
CITATION
ACCJW
AHVBC
NPM
7X8
5PM
ADSXY
ID FETCH-LOGICAL-c4759-ad2d65d60cd23b9ae15d636ee6aad13501306c7e1cca1f5419ddc3f9e990a61c3
IEDL.DBID DOA
ISSN 2373-8731
IngestDate Wed Aug 27 01:31:43 EDT 2025
Thu Aug 21 18:36:22 EDT 2025
Fri Jul 11 12:32:50 EDT 2025
Mon Jul 21 05:56:36 EDT 2025
Thu Apr 24 22:50:52 EDT 2025
Tue Jul 01 03:29:09 EDT 2025
Wed Apr 16 02:20:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4759-ad2d65d60cd23b9ae15d636ee6aad13501306c7e1cca1f5419ddc3f9e990a61c3
Notes Received 13 March 2023. Revision received 1 May 2023. Accepted 3 May 2023. This research did not receive any dedicated funding from any agency in the public, commercial, or not-for-profit sectors. F.D., F.-M.C., M.C., and F.L. are recipients of Career Awards from the Fonds de la Recherche du Québec-Santé. A.F.T. holds a Canada Research Chair in Critical Care Neurology and Trauma. P.S. received honoraria for advertisement boards from Astellas and Paladin Labs. M.Sl. receives a stipend for his role as a Hospital Donation Physician and Regional Medical Lead with the Trillium Gift of Life Network. F.D., R.B., and M.O.M. conceptualized the study. F.D., W.R., D.A., R.B., and M.O.M. participated in the research design. F.D., W.R., D.A., and M.O.M. participated in article selection and data extraction. F.D., R.B., and M.O.M. conducted data analysis. C.I., G.J.B., K.E.A.B., H.C., F.-M.C., M.C., P.C., S.D., S.W.E., A.J.F., S.H., G.K., F.L., S.O., B.R., K.S., D.T., A.F.T., M.J.W., M.Sl., M.Se., and M.O.M. provided content expertise and participated in the data interpretation. All the authors participated in writing the article. Supplemental digital content (SDC) is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal's Web site (www.transplantationdirect.com). Correspondence: Frédérick D'Aragon, MD, Department of Anesthesiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001, 12th Ave N Sherbrooke, QC J1H 5N4, Canada. (frederick.daragon@usherbrooke.ca).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/43a6a8df8ad14bb3b40fe07168d9342e
PMID 37649790
PQID 2859604276
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_43a6a8df8ad14bb3b40fe07168d9342e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10465100
proquest_miscellaneous_2859604276
pubmed_primary_37649790
crossref_primary_10_1097_TXD_0000000000001519
crossref_citationtrail_10_1097_TXD_0000000000001519
wolterskluwer_health_10_1097_TXD_0000000000001519
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-09-01
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: 2023-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Transplantation direct
PublicationTitleAlternate Transplant Direct
PublicationYear 2023
Publisher Lippincott Williams & Wilkins
Wolters Kluwer
Publisher_xml – name: Lippincott Williams & Wilkins
– name: Wolters Kluwer
References Kandaswamy, Stock, Gustafson (R16) 2018; 18
Tufanaru, Munn, Stephenson (R36) 2015; 13
Cicora, Gonzalez, Cicora (R40) 2010; 90
Macleod, O'Collins, Horky (R61) 2005; 25
Hackam, Redelmeier (R60) 2006; 296
St Peter, Moss, Mulligan (R18) 2003; 9
D'Aragon, Lamontagne, Cook (R1) 2020; 67
Shihab, Bennett, Andoh (R25) 2009; 87
R Core Team. The R Project for Statistical Computing. Available at https://www.r-project.org. Accessed June 15, 2023.
Requião-Moura, Durão Junior M, Matos (R2) 2015; 13
Goto, Kim, Shimada (R48) 1991; 52
Belhaj, Dewachter, Hupkens (R53) 2022; 206
Hessheimer, de la Rosa, Gastaca (R8) 2022; 22
Chadban, Ahn, Axelrod (R14) 2020; 104
Quiroga, McShane, Koo (R27) 2006; 21
Liu, Yuan, Luo (R19) 2009; 45
The Cochrane Collaboration. Review Manager Web (RevMan Web). Available at https://revman.cochrane.org. Accessed June 15, 2023.
Shihab, Bennett, Andoh (R41) 2010; 31
McCafferty, Forbes, Thiemermann (R54) 2014; 7
Foroutan, Friesen, Clark (R6) 2019; 14
Lerink, de Kok, Mulvey (R57) 2022; 22
Oltean, Olofsson, Zhu (R24) 2005; 37
Warnecke, Van Raemdonck, Smith (R9) 2018; 6
Sasaki, Miyake, Kinoshita (R45) 2004; 51
Hooijmans, Rovers, de Vries (R30) 2014; 14
HigginsJPTThomasJChandlerJ, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3. Cochrane; 2022. Available at https://training.cochrane.org/handbook .Accessed June 15, 2023.
Lamontagne, Briel, Duffett (R29) 2010; 38
Ponticelli (R3) 2014; 29
Abbasi Dezfouli, Nikdad, Ghamarnejad (R37) 2020; 11
Hüser, Doll, Altomonte (R44) 2009; 32
Cicora, Roberti, Vasquez (R38) 2012; 167
Einecke, Reeve, Halloran (R26) 2017; 17
Lugo-Baruqui, Ayyathurai, Sriram (R13) 2019; 20
Bayer, Das, Baisden (R49) 2013; 146
Kroemer, Dallaporta, Resche-Rigon (R52) 1998; 60
Orban, Fontaine, Cassuto (R56) 2018; 19
Yamanoi, Kohno, Chang (R47) 1994; 15
León Díaz, Fernández Aguilar, Nicolás de Cabo (R7) 2018; 50
Troppmann, Gruessner, Gillingham (R5) 1999; 31
Friedrich, Adhikari, Beyene (R35) 2008; 8
Martinez-Palli, Hirose, Liu (R39) 2011; 26
Menke, Sollinger, Schamberger (R4) 2014; 19
Moers, Smits, Maathuis (R10) 2009; 360
Reutzel-Selke, Zschockelt, Denecke (R42) 2003; 75
van der Worp, Sena, Donnan (R59) 2007; 130
Hausenloy, Maddock, Baxter (R21) 2002; 55
Gruessner, Bartlett, Burke (R17) 1998; 12
Lang, Teng, Chumley (R12) 2007; 117
Tennankore, Kim, Alwayn (R28) 2016; 89
Costanzo, Dipchand, Starling (R15) 2010; 29
Lázaro Fernández, Jado Rodríguez, Torres Redondo, Gowder (R20) 2014
Kawano, Bowers, Kim (R46) 1996; 28
Tarrab, Huet, Brault (R43) 2012; 175
Pitcher, Wang, Tsai (R55) 2005; 129
Cicora, Lausada, Vasquez (R23) 2011; 24
Pillans (R22) 2006; 29
Wight, Chilcott, Holmes (R11) 2003; 7
Friedrich, Adhikari, Herridge (R34) 2005; 142
Oltean, Pullerits, Zhu (R50) 2007; 141
Oltean, Mera, Olofsson (R51) 2006; 38
Zwetsloot, Végh, Jansen of Lorkeers (R58) 2016; 118
Requião-Moura (R2-20240805) 2015; 13
Wight (R11-20240805) 2003; 7
Shihab (R41-20240805) 2010; 31
Moers (R10-20240805) 2009; 360
Lang (R12-20240805) 2007; 117
Foroutan (R6-20240805) 2019; 14
Oltean (R50-20240805) 2007; 141
van der Worp (R59-20240805) 2007; 130
Abbasi Dezfouli (R37-20240805) 2020; 11
León Díaz (R7-20240805) 2018; 50
Quiroga (R27-20240805) 2006; 21
St Peter (R18-20240805) 2003; 9
Kandaswamy (R16-20240805) 2018; 18
Shihab (R25-20240805) 2009; 87
Cicora (R23-20240805) 2011; 24
Hausenloy (R21-20240805) 2002; 55
Reutzel-Selke (R42-20240805) 2003; 75
Martinez-Palli (R39-20240805) 2011; 26
Cicora (R40-20240805) 2010; 90
Menke (R4-20240805) 2014; 19
Hackam (R60-20240805) 2006; 296
Macleod (R61-20240805) 2005; 25
Tufanaru (R36-20240805) 2015; 13
Friedrich (R34-20240805) 2005; 142
Chadban (R14-20240805) 2020; 104
Lerink (R57-20240805) 2022; 22
Troppmann (R5-20240805) 1999; 31
Oltean (R24-20240805) 2005; 37
Pillans (R22-20240805) 2006; 29
Cicora (R38-20240805) 2012; 167
Orban (R56-20240805) 2018; 19
Friedrich (R35-20240805) 2008; 8
Kawano (R46-20240805) 1996; 28
Kroemer (R52-20240805) 1998; 60
Hessheimer (R8-20240805) 2022; 22
Lugo-Baruqui (R13-20240805) 2019; 20
Lamontagne (R29-20240805) 2010; 38
Sasaki (R45-20240805) 2004; 51
McCafferty (R54-20240805) 2014; 7
Hooijmans (R30-20240805) 2014; 14
Liu (R19-20240805) 2009; 45
Costanzo (R15-20240805) 2010; 29
Oltean (R51-20240805) 2006; 38
Hüser (R44-20240805) 2009; 32
Yamanoi (R47-20240805) 1994; 15
Tennankore (R28-20240805) 2016; 89
Zwetsloot (R58-20240805) 2016; 118
D’Aragon (R1-20240805) 2020; 67
Goto (R48-20240805) 1991; 52
Gruessner (R17-20240805) 1998; 12
Einecke (R26-20240805) 2017; 17
Pitcher (R55-20240805) 2005; 129
Warnecke (R9-20240805) 2018; 6
Bayer (R49-20240805) 2013; 146
Belhaj (R53-20240805) 2022; 206
Ponticelli (R3-20240805) 2014; 29
Tarrab (R43-20240805) 2012; 175
References_xml – volume: 206
  start-page: 584
  year: 2022
  end-page: 595
  ident: R53
  article-title: Tacrolimus prevents mechanical and humoral alterations in brain death-induced lung injury in pigs.
  publication-title: Am J Respir Crit Care Med
– volume: 22
  start-page: 344
  year: 2022
  end-page: 370
  ident: R57
  article-title: Preclinical models versus clinical renal ischemia reperfusion injury: a systematic review based on metabolic signatures.
  publication-title: Am J Transplant
– reference: The Cochrane Collaboration. Review Manager Web (RevMan Web). Available at https://revman.cochrane.org. Accessed June 15, 2023.
– volume: 26
  start-page: 1813
  year: 2011
  end-page: 1820
  ident: R39
  article-title: Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model.
  publication-title: Nephrol Dial Transplant
– volume: 13
  start-page: 196
  year: 2015
  end-page: 207
  ident: R36
  article-title: Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness.
  publication-title: Int J Evid Based Healthc
– reference: R Core Team. The R Project for Statistical Computing. Available at https://www.r-project.org. Accessed June 15, 2023.
– volume: 7
  start-page: 1321
  year: 2014
  end-page: 1333
  ident: R54
  article-title: The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.
  publication-title: Dis Model Mech
– volume: 14
  start-page: 43
  year: 2014
  ident: R30
  article-title: SYRCLE's risk of bias tool for animal studies.
  publication-title: BMC Med Res Methodol
– volume: 31
  start-page: 1290
  year: 1999
  end-page: 1292
  ident: R5
  article-title: Impact of delayed function on long-term graft survival after solid organ transplantation.
  publication-title: Transplant Proc
– volume: 38
  start-page: 1775
  year: 2006
  end-page: 1778
  ident: R51
  article-title: Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats.
  publication-title: Transplant Proc
– volume: 130
  start-page: 3063
  year: 2007
  end-page: 3074
  ident: R59
  article-title: Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis.
  publication-title: Brain
– volume: 13
  start-page: 129
  year: 2015
  end-page: 135
  ident: R2
  article-title: Ischemia and reperfusion injury in renal transplantation: hemodynamic and immunological paradigms.
  publication-title: Einstein (São Paulo)
– volume: 141
  start-page: 667
  year: 2007
  end-page: 677
  ident: R50
  article-title: Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats.
  publication-title: Surgery
– volume: 129
  start-page: 202
  year: 2005
  end-page: 220
  ident: R55
  article-title: Preconditioning: gender effects.
  publication-title: J Surg Res
– volume: 142
  start-page: 510
  year: 2005
  end-page: 524
  ident: R34
  article-title: Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.
  publication-title: Ann Intern Med
– volume: 60
  start-page: 619
  year: 1998
  end-page: 642
  ident: R52
  article-title: The mitochondrial death/life regulator in apoptosis and necrosis.
  publication-title: Annu Rev Physiol
– volume: 89
  start-page: 648
  year: 2016
  end-page: 658
  ident: R28
  article-title: Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation.
  publication-title: Kidney Int
– volume: 38
  start-page: 2401
  year: 2010
  end-page: 2408
  ident: R29
  article-title: Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis.
  publication-title: Crit Care Med
– reference: HigginsJPTThomasJChandlerJ, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3. Cochrane; 2022. Available at https://training.cochrane.org/handbook .Accessed June 15, 2023.
– volume: 118
  start-page: 1223
  year: 2016
  end-page: 1232
  ident: R58
  article-title: Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies.
  publication-title: Circ Res
– volume: 52
  start-page: 615
  year: 1991
  end-page: 621
  ident: R48
  article-title: The effects of pretransplant cyclosporine therapy on rats grafted with twelve-hour cold-stored livers-with special reference to reperfusion injury.
  publication-title: Transplantation
– volume: 28
  start-page: 1902
  year: 1996
  end-page: 1903
  ident: R46
  article-title: FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation.
  publication-title: Transplant Proc
– volume: 11
  start-page: 1222
  year: 2020
  ident: R37
  article-title: Oral preconditioning of donors after brain death with calcineurin inhibitors vs. inhibitors of mammalian target for rapamycin in pig kidney transplantation.
  publication-title: Front Immunol
– volume: 50
  start-page: 539
  year: 2018
  end-page: 542
  ident: R7
  article-title: Combined flush with histidine-tryptophan-ketoglutarate and University of Wisconsin solutions in liver transplantation: preliminary results.
  publication-title: Transplant Proc
– volume: 7
  start-page: 1
  year: 2003
  end-page: 94
  ident: R11
  article-title: The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors.
  publication-title: Health Technol Assess
– volume: 17
  start-page: 1346
  year: 2017
  end-page: 1357
  ident: R26
  article-title: Hyalinosis lesions in renal transplant biopsies: time-dependent complexity of interpretation.
  publication-title: Am J Transplant
– volume: 9
  start-page: 105
  year: 2003
  end-page: 116
  ident: R18
  article-title: Effects of tacrolimus on ischemia-reperfusion injury.
  publication-title: Liver Transpl
– year: 2014
  ident: R20
  article-title: Anticalcineurinics: role of mitochondrial transition pore on nephrotoxicity.
  publication-title: Pharmacology and Therapeutics
– volume: 175
  start-page: 333
  year: 2012
  end-page: 342
  ident: R43
  article-title: Cyclosporin-A does not prevent cold ischemia/reperfusion injury of rat livers.
  publication-title: J Surg Res
– volume: 51
  start-page: 76
  year: 2004
  end-page: 83
  ident: R45
  article-title: Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation.
  publication-title: J Med Invest
– volume: 21
  start-page: 1689
  year: 2006
  end-page: 1696
  ident: R27
  article-title: Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
  publication-title: Nephrol Dial Transplant
– volume: 29
  start-page: 1134
  year: 2014
  end-page: 1140
  ident: R3
  article-title: Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
  publication-title: Nephrol Dial Transplant
– volume: 24
  start-page: 107
  year: 2011
  end-page: 112
  ident: R23
  article-title: Protective effect of immunosuppressive treatment before orthotopic kidney autotransplantation.
  publication-title: Transpl Immunol
– volume: 6
  start-page: 357
  year: 2018
  end-page: 367
  ident: R9
  article-title: Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study.
  publication-title: Lancet Respir Med
– volume: 75
  start-page: 1786
  year: 2003
  end-page: 1792
  ident: R42
  article-title: Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors.
  publication-title: Transplantation
– volume: 90
  start-page: 875
  year: 2010
  ident: R40
  article-title: Beneficial effects of immunosuppressive drugs administered to donors in renal transplant: is the combined administration of rapamycin plus tacrolimus more effective than the use of each drug separately.
  publication-title: Transplantation
– volume: 146
  start-page: 1213
  year: 2013
  end-page: 9
  ident: R49
  article-title: Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model.
  publication-title: J Thorac Cardiovasc Surg
– volume: 360
  start-page: 7
  year: 2009
  end-page: 19
  ident: R10
  article-title: Machine perfusion or cold storage in deceased-donor kidney transplantation.
  publication-title: N Engl J Med
– volume: 296
  start-page: 1731
  year: 2006
  end-page: 1732
  ident: R60
  article-title: Translation of research evidence from animals to humans.
  publication-title: JAMA
– volume: 20
  start-page: 6
  year: 2019
  ident: R13
  article-title: Use of mannitol for ischemia reperfusion injury in kidney transplant and partial nephrectomies-review of literature.
  publication-title: Curr Urol Rep
– volume: 22
  start-page: 1169
  year: 2022
  end-page: 1181
  ident: R8
  article-title: Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss.
  publication-title: Am J Transplant
– volume: 32
  start-page: 215
  year: 2009
  end-page: 220
  ident: R44
  article-title: Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat.
  publication-title: Arch Pharm Res
– volume: 8
  start-page: 32
  year: 2008
  ident: R35
  article-title: The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study.
  publication-title: BMC Med Res Methodol
– volume: 29
  start-page: 914
  year: 2010
  end-page: 956
  ident: R15
  article-title: The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients.
  publication-title: J Heart Lung Transplant
– volume: 55
  start-page: 534
  year: 2002
  end-page: 543
  ident: R21
  article-title: Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
  publication-title: Cardiovasc Res
– volume: 167
  start-page: 169
  year: 2012
  end-page: 177
  ident: R38
  article-title: Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.
  publication-title: Clin Exp Immunol
– volume: 15
  start-page: 229
  year: 1994
  end-page: 236
  ident: R47
  article-title: Beneficial effect of donor pretreatment with cyclosporin A in porcine liver transplantation.
  publication-title: Surg Res Comm
– volume: 29
  start-page: 99
  year: 2006
  end-page: 101
  ident: R22
  article-title: Experimental and clinical pharmacology: immunosuppressants-mechanisms of action and monitoring.
  publication-title: Aust Prescr
– volume: 25
  start-page: 713
  year: 2005
  end-page: 721
  ident: R61
  article-title: Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke.
  publication-title: J Cereb Blood Flow Metab
– volume: 12
  start-page: 260
  year: 1998
  end-page: 262
  ident: R17
  article-title: Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.
  publication-title: Clin Transplant
– volume: 104
  start-page: S11
  year: 2020
  end-page: S103
  ident: R14
  article-title: KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation.
  publication-title: Transplantation
– volume: 37
  start-page: 1931
  year: 2005
  end-page: 1933
  ident: R24
  article-title: FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis.
  publication-title: Transplant Proc
– volume: 117
  start-page: 2583
  year: 2007
  end-page: 2591
  ident: R12
  article-title: Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation.
  publication-title: J Clin Invest
– volume: 31
  start-page: 134
  year: 2010
  end-page: 140
  ident: R41
  article-title: Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation.
  publication-title: Am J Nephrol
– volume: 19
  start-page: 395
  year: 2014
  end-page: 400
  ident: R4
  article-title: The effect of ischemia/reperfusion on the kidney graft.
  publication-title: Curr Opin Organ Transplant
– volume: 18
  start-page: 114
  year: 2018
  end-page: 171
  ident: R16
  article-title: OPTN/SRTR 2016 annual data report: pancreas.
  publication-title: Am J Transplant
– volume: 67
  start-page: 992
  year: 2020
  end-page: 1004
  ident: R1
  article-title: Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study.
  publication-title: Can J Anaesth
– volume: 45
  start-page: 141
  year: 2009
  end-page: 147
  ident: R19
  article-title: Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood.
  publication-title: Cytokine
– volume: 19
  start-page: 231
  year: 2018
  ident: R56
  article-title: Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
  publication-title: Trials
– volume: 14
  start-page: 1642
  year: 2019
  end-page: 1650
  ident: R6
  article-title: Risk factors for 1-year graft loss after kidney transplantation: systematic review and meta-analysis.
  publication-title: Clin J Am Soc Nephrol
– volume: 87
  start-page: 326
  year: 2009
  end-page: 329
  ident: R25
  article-title: Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation.
  publication-title: Transplantation
– volume: 8
  start-page: 32
  year: 2008
  ident: R35-20240805
  article-title: The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study.
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-8-32
– volume: 167
  start-page: 169
  year: 2012
  ident: R38-20240805
  article-title: Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2011.04487.x
– volume: 89
  start-page: 648
  year: 2016
  ident: R28-20240805
  article-title: Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation.
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2015.09.002
– volume: 38
  start-page: 2401
  year: 2010
  ident: R29-20240805
  article-title: Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis.
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e3181fa0468
– volume: 38
  start-page: 1775
  year: 2006
  ident: R51-20240805
  article-title: Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats.
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2006.05.002
– volume: 118
  start-page: 1223
  year: 2016
  ident: R58-20240805
  article-title: Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies.
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.115.307676
– volume: 29
  start-page: 1134
  year: 2014
  ident: R3-20240805
  article-title: Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft488
– volume: 75
  start-page: 1786
  year: 2003
  ident: R42-20240805
  article-title: Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors.
  publication-title: Transplantation
  doi: 10.1097/01.TP.0000063408.97289.89
– volume: 60
  start-page: 619
  year: 1998
  ident: R52-20240805
  article-title: The mitochondrial death/life regulator in apoptosis and necrosis.
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev.physiol.60.1.619
– volume: 6
  start-page: 357
  year: 2018
  ident: R9-20240805
  article-title: Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study.
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(18)30136-X
– volume: 117
  start-page: 2583
  year: 2007
  ident: R12-20240805
  article-title: Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation.
  publication-title: J Clin Invest
  doi: 10.1172/JCI31892
– volume: 206
  start-page: 584
  year: 2022
  ident: R53-20240805
  article-title: Tacrolimus prevents mechanical and humoral alterations in brain death–induced lung injury in pigs.
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202201-0033OC
– volume: 15
  start-page: 229
  year: 1994
  ident: R47-20240805
  article-title: Beneficial effect of donor pretreatment with cyclosporin A in porcine liver transplantation.
  publication-title: Surg Res Comm
– volume: 360
  start-page: 7
  year: 2009
  ident: R10-20240805
  article-title: Machine perfusion or cold storage in deceased-donor kidney transplantation.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802289
– volume: 24
  start-page: 107
  year: 2011
  ident: R23-20240805
  article-title: Protective effect of immunosuppressive treatment before orthotopic kidney autotransplantation.
  publication-title: Transpl Immunol
  doi: 10.1016/j.trim.2010.10.006
– volume: 32
  start-page: 215
  year: 2009
  ident: R44-20240805
  article-title: Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat.
  publication-title: Arch Pharm Res
  doi: 10.1007/s12272-009-1138-9
– volume: 14
  start-page: 43
  year: 2014
  ident: R30-20240805
  article-title: SYRCLE’s risk of bias tool for animal studies.
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-14-43
– volume: 7
  start-page: 1
  year: 2003
  ident: R11-20240805
  article-title: The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors.
  publication-title: Health Technol Assess
  doi: 10.3310/hta7250
– volume: 11
  start-page: 1222
  year: 2020
  ident: R37-20240805
  article-title: Oral preconditioning of donors after brain death with calcineurin inhibitors vs. inhibitors of mammalian target for rapamycin in pig kidney transplantation.
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.01222
– volume: 130
  start-page: 3063
  year: 2007
  ident: R59-20240805
  article-title: Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis.
  publication-title: Brain
  doi: 10.1093/brain/awm083
– volume: 50
  start-page: 539
  year: 2018
  ident: R7-20240805
  article-title: Combined flush with histidine-tryptophan-ketoglutarate and University of Wisconsin solutions in liver transplantation: preliminary results.
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2017.12.033
– volume: 31
  start-page: 1290
  year: 1999
  ident: R5-20240805
  article-title: Impact of delayed function on long-term graft survival after solid organ transplantation.
  publication-title: Transplant Proc
  doi: 10.1016/S0041-1345(98)02001-6
– volume: 29
  start-page: 914
  year: 2010
  ident: R15-20240805
  article-title: The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients.
  publication-title: J Heart Lung Transplant
  doi: 10.1016/j.healun.2010.05.034
– volume: 18
  start-page: 114
  year: 2018
  ident: R16-20240805
  article-title: OPTN/SRTR 2016 annual data report: pancreas.
  publication-title: Am J Transplant
  doi: 10.1111/ajt.14558
– volume: 67
  start-page: 992
  year: 2020
  ident: R1-20240805
  article-title: Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study.
  publication-title: Can J Anaesth
  doi: 10.1007/s12630-020-01692-7
– volume: 90
  start-page: 875
  year: 2010
  ident: R40-20240805
  article-title: Beneficial effects of immunosuppressive drugs administered to donors in renal transplant: is the combined administration of rapamycin plus tacrolimus more effective than the use of each drug separately.
  publication-title: Transplantation
  doi: 10.1097/00007890-201007272-01710
– volume: 22
  start-page: 344
  year: 2022
  ident: R57-20240805
  article-title: Preclinical models versus clinical renal ischemia reperfusion injury: a systematic review based on metabolic signatures.
  publication-title: Am J Transplant
  doi: 10.1111/ajt.16868
– volume: 22
  start-page: 1169
  year: 2022
  ident: R8-20240805
  article-title: Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss.
  publication-title: Am J Transplant
  doi: 10.1111/ajt.16899
– volume: 52
  start-page: 615
  year: 1991
  ident: R48-20240805
  article-title: The effects of pretransplant cyclosporine therapy on rats grafted with twelve-hour cold-stored livers—with special reference to reperfusion injury.
  publication-title: Transplantation
  doi: 10.1097/00007890-199110000-00007
– volume: 14
  start-page: 1642
  year: 2019
  ident: R6-20240805
  article-title: Risk factors for 1-year graft loss after kidney transplantation: systematic review and meta-analysis.
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.05560519
– volume: 9
  start-page: 105
  year: 2003
  ident: R18-20240805
  article-title: Effects of tacrolimus on ischemia-reperfusion injury.
  publication-title: Liver Transpl
  doi: 10.1053/jlts.2003.50020
– volume: 175
  start-page: 333
  year: 2012
  ident: R43-20240805
  article-title: Cyclosporin-A does not prevent cold ischemia/reperfusion injury of rat livers.
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2011.04.018
– volume: 55
  start-page: 534
  year: 2002
  ident: R21-20240805
  article-title: Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(02)00455-8
– volume: 104
  start-page: S11
  year: 2020
  ident: R14-20240805
  article-title: KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation.
  publication-title: Transplantation
  doi: 10.1097/TP.0000000000003136
– volume: 20
  start-page: 6
  year: 2019
  ident: R13-20240805
  article-title: Use of mannitol for ischemia reperfusion injury in kidney transplant and partial nephrectomies—review of literature.
  publication-title: Curr Urol Rep
  doi: 10.1007/s11934-019-0868-6
– volume: 142
  start-page: 510
  year: 2005
  ident: R34-20240805
  article-title: Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-142-7-200504050-00010
– volume: 17
  start-page: 1346
  year: 2017
  ident: R26-20240805
  article-title: Hyalinosis lesions in renal transplant biopsies: time-dependent complexity of interpretation.
  publication-title: Am J Transplant
  doi: 10.1111/ajt.14136
– volume: 29
  start-page: 99
  year: 2006
  ident: R22-20240805
  article-title: Experimental and clinical pharmacology: immunosuppressants—mechanisms of action and monitoring.
  publication-title: Aust Prescr
  doi: 10.18773/austprescr.2006.064
– volume: 28
  start-page: 1902
  year: 1996
  ident: R46-20240805
  article-title: FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation.
  publication-title: Transplant Proc
– volume: 129
  start-page: 202
  year: 2005
  ident: R55-20240805
  article-title: Preconditioning: gender effects.
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2005.04.015
– volume: 19
  start-page: 395
  year: 2014
  ident: R4-20240805
  article-title: The effect of ischemia/reperfusion on the kidney graft.
  publication-title: Curr Opin Organ Transplant
  doi: 10.1097/MOT.0000000000000090
– volume: 141
  start-page: 667
  year: 2007
  ident: R50-20240805
  article-title: Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats.
  publication-title: Surgery
  doi: 10.1016/j.surg.2006.11.005
– volume: 13
  start-page: 129
  year: 2015
  ident: R2-20240805
  article-title: Ischemia and reperfusion injury in renal transplantation: hemodynamic and immunological paradigms.
  publication-title: Einstein (São Paulo)
  doi: 10.1590/S1679-45082015RW3161
– volume: 12
  start-page: 260
  year: 1998
  ident: R17-20240805
  article-title: Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.
  publication-title: Clin Transplant
  doi: 10.1111/j.1399-0012.1998.tb01101.x
– volume: 13
  start-page: 196
  year: 2015
  ident: R36-20240805
  article-title: Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness.
  publication-title: Int J Evid Based Healthc
  doi: 10.1097/XEB.0000000000000065
– volume: 21
  start-page: 1689
  year: 2006
  ident: R27-20240805
  article-title: Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfl042
– volume: 19
  start-page: 231
  year: 2018
  ident: R56-20240805
  article-title: Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
  publication-title: Trials
  doi: 10.1186/s13063-018-2597-4
– volume: 31
  start-page: 134
  year: 2010
  ident: R41-20240805
  article-title: Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation.
  publication-title: Am J Nephrol
  doi: 10.1159/000259900
– volume: 296
  start-page: 1731
  year: 2006
  ident: R60-20240805
  article-title: Translation of research evidence from animals to humans.
  publication-title: JAMA
  doi: 10.1001/jama.296.14.1731
– volume: 26
  start-page: 1813
  year: 2011
  ident: R39-20240805
  article-title: Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model.
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfq646
– volume: 51
  start-page: 76
  year: 2004
  ident: R45-20240805
  article-title: Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation.
  publication-title: J Med Invest
  doi: 10.2152/jmi.51.76
– volume: 37
  start-page: 1931
  year: 2005
  ident: R24-20240805
  article-title: FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis.
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2005.02.069
– volume: 7
  start-page: 1321
  year: 2014
  ident: R54-20240805
  article-title: The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.
  publication-title: Dis Model Mech
  doi: 10.1242/dmm.016741
– volume: 45
  start-page: 141
  year: 2009
  ident: R19-20240805
  article-title: Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood.
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2008.12.003
– volume: 87
  start-page: 326
  year: 2009
  ident: R25-20240805
  article-title: Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation.
  publication-title: Transplantation
  doi: 10.1097/TP.0b013e3181945332
– volume: 25
  start-page: 713
  year: 2005
  ident: R61-20240805
  article-title: Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke.
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/sj.jcbfm.9600064
– volume: 146
  start-page: 1213
  year: 2013
  ident: R49-20240805
  article-title: Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model.
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2013.07.030
SSID ssj0001466423
Score 2.2380667
Snippet Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes....
Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. We searched...
Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant...
Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia–reperfusion injury to improve transplant outcomes....
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e1519
SubjectTerms Organ Donation and Procurement
Title Calcineurin Inhibition in Deceased Organ Donors: A Systematic Review and Meta-analysis of Preclinical Studies
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.1097/TXD.0000000000001519
https://www.ncbi.nlm.nih.gov/pubmed/37649790
https://www.proquest.com/docview/2859604276
https://pubmed.ncbi.nlm.nih.gov/PMC10465100
https://doaj.org/article/43a6a8df8ad14bb3b40fe07168d9342e
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1RaxQxEA7SJ0HEYtXVKhF8Dd1NsrlN32rPUgsVwRbubZlNJrRYd6V3pX_fSbJ33KrYF_ctu1l2MzPJTPJNvjD2oURjnCyDsAG80F5qAaoEUSlHBuZQVwk9P_9iTi_12aJebB31FXPCMj1wFtyBVmCg8aEBX-muU50uA5JfNI23SkuMoy_5vK3JVFpdiazpUq33ytnZwcVinrkKx4s8nZ34okTZ_7c48890ySf3Q4Syl99TJvuWPzp5xp6OgSQ_yg3YZY-wf85-HMNNRMrjEjr_3F9ddykji1Npji4iMZ6n3Zd8PvTD7fKQH_FvGy5nnoECDr3n57gCASNjCR8C_0pD47iLko_Jh3vs8uTTxfGpGA9UEC7S-gnw0pvam9J5qToLWFFBGUQDJN0IMdIEws2wIrVWoSY9ee9UsEguC0zl1Au20w89vmJcGW1n2CT2HIppGugk1sGEWnoF2NmCqbVoWzeyjcdDL27aNepNCml_V0jBxOatn5lt44H6H6PWNnUjV3a6QRbUjhbUPmRBBXu_1nlLfSsCJtDjcLdsI7mfiYeRmIK9zDaw-RQNzCQBWxasmVjH5F-mT_rrq8TfHWF1Ggrp1WpiSG3e-vrPFr_-Hy1-wx5LitVyqtw-21nd3uFbiq1W3bvUjX4B_VcebA
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Calcineurin+Inhibition+in+Deceased+Organ+Donors%3A+A+Systematic+Review+and+Meta-analysis+of+Preclinical+Studies&rft.jtitle=Transplantation+direct&rft.au=D%27Aragon%2C+Fr%C3%A9d%C3%A9rick&rft.au=Rousseau%2C+William&rft.au=Breau%2C+Ruth&rft.au=Aminaei%2C+Daniel&rft.date=2023-09-01&rft.issn=2373-8731&rft.eissn=2373-8731&rft.volume=9&rft.issue=9&rft.spage=e1519&rft_id=info:doi/10.1097%2FTXD.0000000000001519&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8731&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8731&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8731&client=summon